MDX 018 shows promising activity in the treatment of an undisclosed autoimmune disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1470, 2005-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fosmidomycin shows promising antimalarial activity

By  

Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Sitafloxacin shows promising in vitro activity against Mycobacterium ulcerans infection

By  

Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Citalopram shows promising activity in recurrent abdominal pain in children and adolescents

By  

Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Torcetrapib: promising in the treatment of cardiovascular disease

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Natalizumab shows potential in the treatment of Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite